Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rare Diseases | 5 | 2023 | 622 | 1.770 |
Why?
|
Oligonucleotides, Antisense | 3 | 2023 | 458 | 1.420 |
Why?
|
RNA Splicing | 6 | 2023 | 898 | 1.340 |
Why?
|
Ataxia Telangiectasia | 3 | 2023 | 107 | 1.240 |
Why?
|
Autistic Disorder | 8 | 2021 | 1219 | 1.140 |
Why?
|
Genetic Diseases, Inborn | 3 | 2024 | 604 | 0.890 |
Why?
|
Tay-Sachs Disease | 1 | 2022 | 20 | 0.800 |
Why?
|
Genetic Testing | 14 | 2024 | 3533 | 0.780 |
Why?
|
Allelic Imbalance | 1 | 2019 | 77 | 0.640 |
Why?
|
Oligonucleotides | 1 | 2022 | 566 | 0.640 |
Why?
|
Genes, Recessive | 2 | 2019 | 623 | 0.630 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.620 |
Why?
|
Microcephaly | 5 | 2017 | 425 | 0.580 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 656 | 0.550 |
Why?
|
Neonatal Screening | 6 | 2023 | 597 | 0.520 |
Why?
|
Phenotype | 19 | 2024 | 16571 | 0.490 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 662 | 0.470 |
Why?
|
Information Dissemination | 1 | 2023 | 1125 | 0.460 |
Why?
|
Mutation | 23 | 2024 | 30016 | 0.460 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1034 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 13 | 2021 | 17878 | 0.440 |
Why?
|
Mutation, Missense | 4 | 2019 | 2570 | 0.430 |
Why?
|
Genetic Association Studies | 8 | 2021 | 2734 | 0.430 |
Why?
|
Fragile X Syndrome | 1 | 2014 | 116 | 0.430 |
Why?
|
Sequence Analysis, DNA | 8 | 2019 | 4739 | 0.400 |
Why?
|
Abnormalities, Multiple | 5 | 2024 | 1422 | 0.390 |
Why?
|
Nerve Tissue Proteins | 7 | 2016 | 4408 | 0.390 |
Why?
|
Centrioles | 3 | 2016 | 80 | 0.380 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2017 | 3608 | 0.370 |
Why?
|
Exons | 4 | 2023 | 2381 | 0.360 |
Why?
|
Genome, Human | 7 | 2023 | 4421 | 0.330 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2010 | 350 | 0.330 |
Why?
|
Genetics, Medical | 2 | 2023 | 334 | 0.330 |
Why?
|
Genomics | 10 | 2024 | 5822 | 0.320 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7995 | 0.310 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2024 | 846 | 0.300 |
Why?
|
Critical Illness | 2 | 2024 | 2709 | 0.300 |
Why?
|
Growth Cones | 3 | 2003 | 117 | 0.290 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2021 | 3708 | 0.260 |
Why?
|
Pedigree | 9 | 2024 | 4539 | 0.250 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2014 | 600 | 0.250 |
Why?
|
Humans | 75 | 2024 | 760617 | 0.230 |
Why?
|
Gyrus Cinguli | 1 | 2010 | 1115 | 0.230 |
Why?
|
Osteochondrodysplasias | 2 | 2017 | 182 | 0.230 |
Why?
|
Intracranial Thrombosis | 1 | 2005 | 108 | 0.230 |
Why?
|
Introns | 2 | 2023 | 968 | 0.220 |
Why?
|
Cell Cycle Proteins | 4 | 2017 | 3447 | 0.220 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2024 | 138 | 0.220 |
Why?
|
Infant, Newborn | 17 | 2024 | 26180 | 0.200 |
Why?
|
Cerebral Revascularization | 1 | 2005 | 259 | 0.200 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2016 | 343 | 0.200 |
Why?
|
Ribosomal Proteins | 1 | 2024 | 370 | 0.200 |
Why?
|
Databases, Genetic | 4 | 2017 | 1742 | 0.200 |
Why?
|
Nervous System | 2 | 2003 | 545 | 0.190 |
Why?
|
Pharmacogenetics | 2 | 2023 | 675 | 0.190 |
Why?
|
Cerebral Cortex | 3 | 2014 | 5776 | 0.190 |
Why?
|
Developmental Disabilities | 3 | 2024 | 1509 | 0.190 |
Why?
|
Genetic Variation | 5 | 2022 | 6561 | 0.190 |
Why?
|
Axons | 3 | 2004 | 1671 | 0.180 |
Why?
|
Cell Adhesion Molecules | 3 | 2004 | 1602 | 0.180 |
Why?
|
Cognition Disorders | 1 | 2014 | 3979 | 0.180 |
Why?
|
Receptors, Immunologic | 3 | 2004 | 1409 | 0.170 |
Why?
|
Thrombectomy | 1 | 2005 | 702 | 0.170 |
Why?
|
DNA Copy Number Variations | 5 | 2020 | 2020 | 0.170 |
Why?
|
Genome-Wide Association Study | 6 | 2017 | 12661 | 0.170 |
Why?
|
Brain | 7 | 2022 | 27101 | 0.170 |
Why?
|
Histone Acetyltransferases | 1 | 2021 | 335 | 0.170 |
Why?
|
Thiolester Hydrolases | 1 | 2020 | 90 | 0.160 |
Why?
|
Coloboma | 1 | 2019 | 59 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 564 | 0.160 |
Why?
|
Nervous System Malformations | 2 | 2019 | 244 | 0.150 |
Why?
|
Child | 19 | 2024 | 80079 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2017 | 3634 | 0.150 |
Why?
|
Genes, DCC | 1 | 2017 | 10 | 0.150 |
Why?
|
Receptors, Cell Surface | 4 | 2017 | 2802 | 0.150 |
Why?
|
Cell Communication | 2 | 2003 | 1654 | 0.150 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 17 | 0.150 |
Why?
|
Drugs, Investigational | 1 | 2019 | 212 | 0.140 |
Why?
|
Homozygote | 2 | 2020 | 1776 | 0.140 |
Why?
|
Congenital Abnormalities | 1 | 2022 | 709 | 0.140 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 2 | 2016 | 48 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6925 | 0.140 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 283 | 0.140 |
Why?
|
Genetic Privacy | 1 | 2017 | 59 | 0.140 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2016 | 62 | 0.130 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1661 | 0.130 |
Why?
|
Infant | 11 | 2024 | 36152 | 0.130 |
Why?
|
Bioethical Issues | 1 | 2017 | 120 | 0.130 |
Why?
|
Health | 1 | 2019 | 398 | 0.130 |
Why?
|
Periventricular Nodular Heterotopia | 2 | 2014 | 53 | 0.130 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2016 | 233 | 0.120 |
Why?
|
Body Dysmorphic Disorders | 1 | 2019 | 243 | 0.120 |
Why?
|
Seizures | 3 | 2019 | 2954 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2015 | 184 | 0.120 |
Why?
|
Intracranial Aneurysm | 1 | 2005 | 1285 | 0.120 |
Why?
|
Ataxia | 1 | 2017 | 306 | 0.120 |
Why?
|
Cerebellum | 2 | 2019 | 1501 | 0.120 |
Why?
|
Male | 37 | 2024 | 360358 | 0.120 |
Why?
|
Infant Mortality | 1 | 2019 | 751 | 0.120 |
Why?
|
Cell Differentiation | 4 | 2016 | 11514 | 0.120 |
Why?
|
Female | 34 | 2024 | 392148 | 0.110 |
Why?
|
Chromosome Mapping | 4 | 2021 | 4611 | 0.110 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2014 | 43 | 0.110 |
Why?
|
DNA Mutational Analysis | 4 | 2016 | 4110 | 0.110 |
Why?
|
Hypertrichosis | 1 | 2013 | 31 | 0.110 |
Why?
|
Retinitis Pigmentosa | 1 | 2017 | 397 | 0.110 |
Why?
|
KATP Channels | 1 | 2013 | 48 | 0.110 |
Why?
|
Myopathies, Nemaline | 1 | 2013 | 73 | 0.110 |
Why?
|
Disease | 1 | 2019 | 670 | 0.110 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2014 | 88 | 0.110 |
Why?
|
Myofibrils | 1 | 2013 | 141 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 210 | 0.110 |
Why?
|
Caenorhabditis elegans Proteins | 4 | 2004 | 871 | 0.110 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1386 | 0.110 |
Why?
|
Walker-Warburg Syndrome | 1 | 2012 | 15 | 0.100 |
Why?
|
Microfilament Proteins | 3 | 2019 | 1130 | 0.100 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2014 | 361 | 0.100 |
Why?
|
Gene Deletion | 1 | 2020 | 2661 | 0.100 |
Why?
|
Consanguinity | 2 | 2014 | 456 | 0.100 |
Why?
|
Family | 5 | 2018 | 3193 | 0.100 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 144 | 0.100 |
Why?
|
Muscle Development | 1 | 2014 | 259 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2017 | 15908 | 0.100 |
Why?
|
Malformations of Cortical Development | 1 | 2014 | 176 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5789 | 0.100 |
Why?
|
Glycosyltransferases | 1 | 2012 | 115 | 0.100 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 294 | 0.100 |
Why?
|
Drug Discovery | 1 | 2019 | 1051 | 0.100 |
Why?
|
Neuromuscular Diseases | 1 | 2014 | 258 | 0.100 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 451 | 0.090 |
Why?
|
Microtubule-Associated Proteins | 1 | 2016 | 1074 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 610 | 0.090 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3794 | 0.090 |
Why?
|
Contractile Proteins | 1 | 2012 | 240 | 0.090 |
Why?
|
Cardiomegaly | 1 | 2013 | 590 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 339 | 0.090 |
Why?
|
Genetic Loci | 2 | 2021 | 2624 | 0.090 |
Why?
|
Neural Pathways | 1 | 2001 | 3056 | 0.090 |
Why?
|
Cilia | 1 | 2014 | 492 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Neurons | 5 | 2023 | 9438 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 835 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4391 | 0.090 |
Why?
|
DNA Replication | 1 | 2017 | 1414 | 0.090 |
Why?
|
Quantitative Trait, Heritable | 1 | 2013 | 540 | 0.090 |
Why?
|
Prospective Studies | 4 | 2023 | 54360 | 0.090 |
Why?
|
Family Health | 2 | 2013 | 1253 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8618 | 0.090 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2013 | 386 | 0.080 |
Why?
|
Central Nervous System | 1 | 2017 | 1333 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 678 | 0.080 |
Why?
|
Child, Preschool | 9 | 2024 | 42188 | 0.080 |
Why?
|
Williams Syndrome | 1 | 2011 | 194 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1006 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6174 | 0.080 |
Why?
|
Facies | 2 | 2021 | 222 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2013 | 725 | 0.080 |
Why?
|
Child Development | 1 | 2019 | 2300 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6762 | 0.070 |
Why?
|
Head | 1 | 2013 | 922 | 0.070 |
Why?
|
Caenorhabditis elegans | 4 | 2004 | 1452 | 0.070 |
Why?
|
Protein Kinases | 1 | 2014 | 1606 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3509 | 0.070 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1125 | 0.070 |
Why?
|
Doxorubicin | 1 | 2013 | 2224 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7050 | 0.070 |
Why?
|
Point Mutation | 1 | 2012 | 1595 | 0.070 |
Why?
|
Epilepsy | 2 | 2019 | 3288 | 0.070 |
Why?
|
Animals | 16 | 2019 | 168201 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17629 | 0.070 |
Why?
|
Amino Acid Sequence | 5 | 2019 | 13441 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2019 | 22148 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2003 | 9586 | 0.070 |
Why?
|
Genetic Counseling | 2 | 2021 | 627 | 0.070 |
Why?
|
Cohort Studies | 3 | 2021 | 41457 | 0.060 |
Why?
|
Skin | 1 | 2019 | 4473 | 0.060 |
Why?
|
United States | 6 | 2024 | 72272 | 0.060 |
Why?
|
Syndrome | 2 | 2024 | 3268 | 0.060 |
Why?
|
Synapses | 1 | 2014 | 1755 | 0.060 |
Why?
|
Brain Diseases | 1 | 2014 | 1545 | 0.060 |
Why?
|
Helminth Proteins | 2 | 2002 | 172 | 0.060 |
Why?
|
Comparative Genomic Hybridization | 2 | 2016 | 473 | 0.060 |
Why?
|
Genotype | 5 | 2021 | 12978 | 0.060 |
Why?
|
Adolescent | 9 | 2024 | 88234 | 0.060 |
Why?
|
Myopathies, Structural, Congenital | 2 | 2016 | 103 | 0.060 |
Why?
|
Parents | 1 | 2018 | 3563 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12758 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2005 | 266 | 0.060 |
Why?
|
Electroencephalography | 1 | 2019 | 6237 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2669 | 0.050 |
Why?
|
Software | 1 | 2017 | 4431 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7583 | 0.050 |
Why?
|
Case Management | 1 | 2005 | 272 | 0.050 |
Why?
|
Immunoprecipitation | 2 | 2016 | 876 | 0.050 |
Why?
|
Signal Transduction | 5 | 2016 | 23416 | 0.050 |
Why?
|
Chromatin | 1 | 2014 | 2955 | 0.050 |
Why?
|
Zebrafish | 4 | 2014 | 3007 | 0.050 |
Why?
|
Adult | 11 | 2024 | 220969 | 0.050 |
Why?
|
RNA Splice Sites | 1 | 2023 | 210 | 0.050 |
Why?
|
Haploinsufficiency | 1 | 2024 | 336 | 0.050 |
Why?
|
Retroelements | 1 | 2023 | 162 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2005 | 383 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
Blepharophimosis | 1 | 2021 | 21 | 0.050 |
Why?
|
Congenital Hypothyroidism | 1 | 2021 | 40 | 0.050 |
Why?
|
Proteins | 2 | 2013 | 6030 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4345 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2004 | 1557 | 0.050 |
Why?
|
Transcription Factors | 1 | 2021 | 12116 | 0.050 |
Why?
|
DNA Repair | 1 | 2010 | 2043 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2016 | 18937 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2013 | 3796 | 0.050 |
Why?
|
Scrotum | 1 | 2021 | 116 | 0.050 |
Why?
|
Psychomotor Disorders | 1 | 2021 | 149 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2016 | 3220 | 0.040 |
Why?
|
Teaching | 1 | 2008 | 1169 | 0.040 |
Why?
|
Neurology | 1 | 2008 | 780 | 0.040 |
Why?
|
Schizophrenia | 2 | 2016 | 6929 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2456 | 0.040 |
Why?
|
Patella | 1 | 2021 | 315 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3954 | 0.040 |
Why?
|
Cerebral Angiography | 1 | 2005 | 1281 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 196 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6861 | 0.040 |
Why?
|
Craniofacial Abnormalities | 1 | 2021 | 319 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
Focus Groups | 1 | 2024 | 1409 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 899 | 0.040 |
Why?
|
Protein Conformation | 2 | 2017 | 3965 | 0.040 |
Why?
|
Rats | 2 | 2013 | 23717 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 6 | 2017 | 36402 | 0.040 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2005 | 1033 | 0.040 |
Why?
|
Distal Myopathies | 1 | 2016 | 18 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 68 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 59179 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2019 | 497 | 0.030 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2016 | 43 | 0.030 |
Why?
|
Minority Groups | 1 | 2024 | 1202 | 0.030 |
Why?
|
Dentate Gyrus | 1 | 1997 | 165 | 0.030 |
Why?
|
Genetic Research | 1 | 2017 | 171 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2371 | 0.030 |
Why?
|
Models, Molecular | 2 | 2017 | 5433 | 0.030 |
Why?
|
Base Sequence | 2 | 2017 | 12421 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2017 | 392 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 1418 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18221 | 0.030 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1357 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6074 | 0.030 |
Why?
|
Aminoacylation | 1 | 2014 | 9 | 0.030 |
Why?
|
Lissencephaly | 1 | 2014 | 36 | 0.030 |
Why?
|
Dystroglycans | 1 | 2014 | 62 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7373 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2017 | 1162 | 0.030 |
Why?
|
Joint Instability | 1 | 2021 | 801 | 0.030 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 53 | 0.030 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2016 | 265 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2024 | 2985 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9345 | 0.030 |
Why?
|
Mental Disorders | 1 | 2013 | 6826 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
Cell Movement | 3 | 2004 | 5200 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2013 | 186 | 0.030 |
Why?
|
Genomic Instability | 1 | 2017 | 709 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 1 | 2014 | 460 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8516 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2013 | 262 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2864 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2013 | 208 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Clathrin Heavy Chains | 1 | 2012 | 27 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 93 | 0.020 |
Why?
|
Heterozygote | 1 | 2019 | 2780 | 0.020 |
Why?
|
Informed Consent | 1 | 2018 | 1007 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2017 | 2340 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2014 | 226 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3302 | 0.020 |
Why?
|
Status Epilepticus | 1 | 1997 | 460 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2013 | 493 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2005 | 3028 | 0.020 |
Why?
|
Heart Defects, Congenital | 2 | 2021 | 4671 | 0.020 |
Why?
|
Aged | 2 | 2019 | 169042 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2013 | 341 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7568 | 0.020 |
Why?
|
Glycosylation | 1 | 2014 | 1098 | 0.020 |
Why?
|
Algorithms | 2 | 2017 | 14018 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2011 | 122 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2005 | 5293 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3333 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2012 | 1301 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 982 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1712 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 634 | 0.020 |
Why?
|
Gene Duplication | 1 | 2011 | 314 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2014 | 768 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2178 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 597 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 733 | 0.020 |
Why?
|
Embryonic Development | 1 | 2014 | 721 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
Attitude to Health | 1 | 2018 | 2024 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2189 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2014 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1503 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2011 | 321 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 504 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5034 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1835 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 748 | 0.020 |
Why?
|
Binding Sites | 1 | 2017 | 6051 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1670 | 0.020 |
Why?
|
Mice | 4 | 2017 | 81368 | 0.020 |
Why?
|
Intelligence | 1 | 2013 | 923 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2011 | 455 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2013 | 1336 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
Internship and Residency | 1 | 2008 | 5878 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1503 | 0.020 |
Why?
|
Siblings | 1 | 2011 | 824 | 0.020 |
Why?
|
Cadherins | 1 | 2011 | 901 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1066 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4237 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1852 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2655 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7045 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1594 | 0.020 |
Why?
|
Education | 1 | 2008 | 534 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3792 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3238 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2894 | 0.020 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases | 1 | 2004 | 8 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1896 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3419 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4137 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6233 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7389 | 0.010 |
Why?
|
Genes, Helminth | 1 | 2004 | 146 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 80566 | 0.010 |
Why?
|
Genes, Suppressor | 1 | 2003 | 47 | 0.010 |
Why?
|
Pregnancy | 2 | 2017 | 29868 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3777 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2005 | 15612 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 1894 | 0.010 |
Why?
|
Nerve Net | 1 | 2014 | 2290 | 0.010 |
Why?
|
rac GTP-Binding Proteins | 1 | 2003 | 162 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9643 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15689 | 0.010 |
Why?
|
Clinical Clerkship | 1 | 2008 | 564 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2012 | 1906 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14389 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2895 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15576 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2004 | 813 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14648 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 2001 | 460 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9529 | 0.010 |
Why?
|
Crohn Disease | 1 | 2013 | 2279 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10073 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15251 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5964 | 0.010 |
Why?
|
Cues | 1 | 2004 | 875 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10432 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1068 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3315 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 836 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4947 | 0.010 |
Why?
|
Microtubules | 1 | 2004 | 1073 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15828 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2005 | 64568 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7196 | 0.010 |
Why?
|
Parasympathomimetics | 1 | 1997 | 27 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2008 | 2756 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7512 | 0.010 |
Why?
|
Mutagenesis | 1 | 2001 | 1230 | 0.010 |
Why?
|
Pilocarpine | 1 | 1997 | 64 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1997 | 310 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23972 | 0.010 |
Why?
|
Muscles | 1 | 2001 | 1573 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5091 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2063 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2013 | 4764 | 0.010 |
Why?
|
Middle Aged | 2 | 2012 | 220584 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9417 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3730 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74115 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1997 | 1734 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5780 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4457 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 1997 | 1433 | 0.000 |
Why?
|
Models, Biological | 1 | 2004 | 9461 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8166 | 0.000 |
Why?
|